Patients with food allergy have a sensitization to a specific food or foods and manifest a reproducible immune response whenever exposed to food-based allergens. The true prevalence of food allergy...
Recent work at the MassGeneral for Hospital Children’s Developmental Immunology Program reveals potential therapeutic targets for staph-related infections, inflammatory bowel disease, Alzheimer’s...
Johns Hopkins scientists have identified a molecular marker called “Mig 6” that appears to accurately predict longer survival -- up to two years -- among patients prescribed two of the most widely...
A strategy developed by Massachusetts General Hospital (MGH)-based investigators to increase levels of beneficial high-density lipoprotein (HDL) has been shown for the first time to be effective in...
New research indicates that a disruption of brain signals for reward and punishment contributes to increased pain sensitivity, known as hyperalgesia, in fibromyalgia patients. Results published in...
Exemestane, a synthetic steroid drug widely prescribed to fight breast cancers that thrive on estrogens, not only inhibits the production of the hormone, but also appears to protect cells throughout...
Melanoma treatment is changing dramatically – and for the better. The Food and Drug Administration’s (FDA) recent approval of two new drugs, Tafinlar® (dabrafenib) and Mekinist® (trametinib), to...
Inflammatory Bowel Disease (IBD) can be a complex disease to treat. As part of Massachusetts General Hospital's multidisciplinary approach for IBD management, patients receive treatment from an...
A team led by MGH researchers has identified a genetic signature that may reflect the risk of tumor recurrence or spread in men surgically treated for prostate cancer. If confirmed, the genetic risk...
Researchers say it’s clear that some cases of autism are hereditary, but have struggled to draw direct links between the condition and particular genes. Now a team at the Johns Hopkins University...

Pages